接种改良活马疱疹病毒1型gM缺失突变株(RacHΔgM)的马驹对感染获得部分保护
本研究为纵向、前瞻性实验研究,两组断奶马驹(每组n=6)分别接种两剂马疱疹病毒1型gM缺失突变株(RacHΔgM)或作对照,间隔六周经鼻内和肌内同时接种,第二次接种后四周以EHV-1 Ab4/8鼻内攻毒。疫苗接种未引起不良事件,并诱导显著更高的补体结合抗体和病毒中和抗体;攻毒后接种组发热持续时间与幅度、鼻咽排毒和细胞相关病毒血症均减少,但病毒学完全保护需进一步研究。
要点
- 两组断奶马驹每组n=6,接种RacHΔgM或对照,间隔六周经鼻内和肌内同时接种两剂。
- 疫苗接种未引起不良事件,血清补体结合抗体和病毒中和抗体显著高于对照组。
- 攻毒后接种组发热持续时间与幅度、鼻咽排毒和细胞相关病毒血症减少。
核心结论
- RacHΔgM改良活疫苗在断奶马驹中启动了EHV-1特异性体液免疫应答,但疫苗对EHV-1的完全病毒学保护需进一步研究。
研究设计与样本
- 纵向、前瞻性实验研究,两组断奶马驹每组n=6,分别接种两剂RacHΔgM或作对照,间隔六周经鼻内和肌内同时接种,第二次接种后四周以EHV-1 Ab4/8鼻内攻毒。
主要发现
- 疫苗接种未引起不良事件,但接种组血清补体结合抗体和病毒中和抗体在等效时间点或接种前时间点均显著高于对照组。
- 接种组与对照组鼻咽病毒特异性抗体水平和细胞毒性T淋巴细胞应答无显著差异。
- 攻毒后接种组发热持续时间与幅度、鼻咽排毒和细胞相关病毒血症均减少。
局限性
- 原文结论指出疫苗对EHV-1的完全病毒学保护需进一步研究。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Equid herpesvirus-1 (EHV-1) causes respiratory and neurological disease and late gestation abortion in pregnant mares. Current vaccines contain either inactivated or live EHV-1, but fail to provide complete clinical or virological protection, namely prevention of nasopharyngeal shedding and cell-associated viraemia. Thus, the development of novel products, such as modified live virus (MLV) vaccines which stimulate virus-specific, humoral and cell mediated immune responses more effectively remains a priority. Two groups of weaned foals (n = 6 each group) were used in a longitudinal, prospective, experimental study to evaluate immune responses elicited by two vaccinations with a glycoprotein M (gM) deletion mutant of EHV-1 (RacHdeltagM). Following two concurrent intranasal and intramuscular inoculations six weeks apart, vaccinated (8.4 ± 0.2 months old) and control foals (6.2 ± 0.4 months) were challenge infected intranasally with EHV-1 Ab4/8 four weeks after the second vaccination and clinical signs and virological replication measured. Vaccination caused no adverse events, but did stimulate significantly higher complement fixing and virus neutralizing antibodies in serum compared with control foals at either equivalent or pre-vaccination time points. Virus-specific nasopharyngeal antibody levels and cytotoxic T lymphocyte responses were not significantly different between the groups. Following challenge infection, these immune responses were associated with a reduction in clinical signs and virological replication in the vaccinated foals, including a reduction in duration and magnitude of pyrexia, nasopharyngeal shedding and cell-associated viraemia. We conclude that the RacHΔgM MLV primed EHV-1-specific humoral immune responses in weaned foals. However, complete virological protection by vaccination against EHV-1 requires further research.
引用
- Kydd JH, Hannant D, Robinson RS, et al. Vaccination of foals with a modified live, equid herpesvirus-1 gM deletion mutant (RacHΔgM) confers partial protection against infection. Vaccine. 2019. PMID: 31629571. doi:10.1016/j.vaccine.2019.09.106
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。